Loading organizations...
§ Private Profile · Denver, CO, USA
Maya Health is a technology company.
Maya Health develops a mobile application, Maya, designed as a smart personal health assistant for women. The platform offers comprehensive tracking capabilities including period and fertility prediction, personalized health insights, and detailed reports. It also integrates a community feature, allowing users to connect, and provides specific tools for pregnancy tracking, leveraging technology to manage and understand various aspects of women's reproductive health.
Plackal Tech, the parent company behind Maya, was founded around 2011 or 2012 by John Paul Plackal and Jane Mary John. The founders conceived of Maya with the insight that women needed a holistic, technology-driven solution to manage their health, from menstrual cycles to pregnancy. John Paul Plackal, an alumnus of the Indian Institute of Management, Bangalore, played a key role in establishing the company's focus on mobile health solutions.
Maya serves a global user base of women seeking to monitor and understand their reproductive health, evidenced by its widespread adoption. The company's vision centers on empowering women worldwide by providing accessible and actionable health information through its app. It aims to foster a supportive community while delivering precise data and insights, ultimately enabling users to proactively manage their well-being and stay informed about their health journey.
Maya Health has raised $4.4M across 2 funding rounds.
Maya Health has raised $4.4M in total across 2 funding rounds.
Maya Health is a technology company that builds a software platform focused on tracking, measuring, and illustrating health outcomes, specifically in the emerging field of psychedelic medicine. It serves practitioners, participants, and researchers involved in psychedelic healthcare by providing real-world data to support safe and effective practices. The platform addresses the problem of fragmented data and lack of standardized outcome measurement in psychedelic therapy, enabling better clinical decision-making and research collaboration. Since its founding in 2019, Maya Health has shown growth momentum by establishing itself as a key player in this niche healthcare technology space, with a small but specialized team and funding under $5 million[1][3][6].
Maya Health was founded in 2019 and is headquartered in Denver, Colorado. The company was co-founded by David Champion, who serves as CEO. The idea emerged from the need to better understand and optimize the therapeutic journey in psychedelic medicine, a field that is rapidly evolving but lacks comprehensive data infrastructure. Early traction came from building a platform that connects psychedelic providers, participants, and researchers to collectively chart safe and effective practices, which has helped Maya carve out a unique position in this specialized healthcare segment[1][3][4][6].
Maya Health rides the wave of increasing acceptance and legalization of psychedelic therapies for mental health conditions, a trend driven by growing scientific evidence and regulatory shifts. The timing is critical as the psychedelic medicine field transitions from experimental to more mainstream clinical practice, creating demand for robust data platforms to ensure safety, efficacy, and regulatory compliance. Market forces such as rising mental health awareness, digital health adoption, and AI-driven analytics favor Maya Health’s growth. By providing infrastructure for outcome tracking and data sharing, Maya Health influences the broader ecosystem by enabling safer, more effective psychedelic treatments and accelerating research in this novel therapeutic area[1][3][4][6].
Looking ahead, Maya Health is poised to expand its platform capabilities, potentially integrating advanced AI analytics and broader clinical data to deepen insights into psychedelic therapy outcomes. Trends such as increased regulatory approvals, insurance coverage, and mainstream adoption of psychedelic treatments will shape its journey. As the psychedelic healthcare ecosystem matures, Maya Health’s influence may grow from a niche data provider to a foundational technology partner for providers, researchers, and regulators, helping to standardize and scale safe psychedelic medicine practices globally. This evolution ties back to its core mission of empowering the psychedelic medicine community through data-driven insights and collaboration[1][3][4][6].
Maya Health has raised $4.4M in total across 2 funding rounds.
Maya Health's investors include Bek Nurgazy, Henri Sant-Cassia, Cosmo Feilding Mellen, Craig Nerenberg, Heather Jackson, Mark Zittman, Meyer Mishkin, Michael Blitzer, Noah Levy, Ambria Capital, Aquanta Group, BWC Group.
Maya Health has raised $4.4M across 2 funding rounds. Most recently, it raised $4.3M Other Equity / Seed in December 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Dec 17, 2021 | $4.3M Venture Round | BEK Nurgazy, Henri Sant Cassia | Cosmo Feilding Mellen, Craig Nerenberg, Heather Jackson, Mark Zittman, Meyer Mishkin, Michael Blitzer, Noah Levy, Ambria Capital, Aquanta Group, BWC Group, Deep END Partners, Heather Jackson Revocable Trust, KP Investment Partners, MA Financial, Mark A. Zittman Revocable Trust, Nicholas Henry Moryl Revocable Trust, Psynergia Labs, Rinat Family 2006 Trust | Announced |
| Sep 1, 2020 | $100K Seed | — | Mystic Ventures, PsyMed Ventures | Announced |